Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
HTFL Insider Trading and Fund Holdings (Heartflow, Inc.) · https://wallstpal.com/stock/htfl/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1464521

Heartflow, Inc. (HTFL): Insider Trades and Fund Holdings

In the past 12 months, Heartflow, Inc. insiders reported no open-market purchases and 21 sales worth $17.7M; 21 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$17.7MSold by insiders, 12 months
1Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Oct 22, 2026Insider saleChief Medical Officer Campbell Rogers sold $1.3 million under a 10b5-1 plan
  2. Oct 22, 2026Planned saleRogers Campbell (officer) filed notice to sell about $1.3 million around Oct 22, 2026
  3. Oct 22, 2026Planned saleRogers Campbell (member of immediate family of any of the foregoing) filed notice to sell about $311,027 around Oct 22, 2026
  4. Oct 13, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $1.9 million around Oct 12, 2026
  5. Oct 12, 2026Insider saleCEO John C.m. Farquhar sold $1.9 million under a 10b5-1 plan
  6. Sep 18, 2026Insider saleChief Medical Officer Campbell Rogers sold $987,052 under a 10b5-1 plan
  7. Sep 18, 2026Insider saleCFO Vikram Verghese sold $850,926 under a 10b5-1 plan
  8. Sep 18, 2026Planned saleRogers Campbell (officer) filed notice to sell about $987,052 around Sep 18, 2026
  9. Sep 18, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $850,927 around Sep 18, 2026
  10. Sep 18, 2026Planned saleRogers Campbell (member of immediate family of any of the foregoing) filed notice to sell about $283,498 around Sep 18, 2026
  11. Sep 17, 2026Insider saleCFO Vikram Verghese sold $379,816 under a 10b5-1 plan
  12. Sep 17, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $379,815 around Sep 17, 2026
  13. Sep 15, 2026Insider saleCFO Vikram Verghese sold $33,408 under a 10b5-1 plan
  14. Sep 15, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $33,408 around Sep 15, 2026
  15. Sep 14, 2026Insider saleCFO Vikram Verghese sold $230,744 under a 10b5-1 plan
  16. Sep 14, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $230,744 around Sep 14, 2026
  17. Sep 11, 2026Insider saleCFO Vikram Verghese sold $1.5 million under a 10b5-1 plan
  18. Sep 11, 2026Insider saleCEO John C.m. Farquhar sold $194,500 under a 10b5-1 plan
  19. Sep 11, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $1.5 million around Sep 11, 2026
  20. Sep 11, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $194,500 around Sep 11, 2026
  21. Sep 10, 2026Insider saleCEO John C.m. Farquhar sold $1.6 million under a 10b5-1 plan
  22. Sep 10, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $1.6 million around Sep 10, 2026
  23. Sep 8, 2026Insider saleCFO Vikram Verghese sold $332,212 under a 10b5-1 plan
  24. Sep 8, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $332,212 around Sep 8, 2026
  25. Sep 3, 2026Insider saleCFO Vikram Verghese sold $1.4 million under a 10b5-1 plan
  26. Sep 3, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $1.4 million around Sep 3, 2026
  27. Sep 2, 2026Insider saleCFO Vikram Verghese sold $297,326 under a 10b5-1 plan
  28. Sep 2, 2026Planned saleVerghese Vikram (officer) filed notice to sell about $297,326 around Sep 2, 2026
  29. Aug 21, 2026Insider saleCEO John C.m. Farquhar sold $1.4 million under a 10b5-1 plan
  30. Aug 21, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $1.4 million around Aug 21, 2026
  31. Aug 18, 2026Insider saleCEO John C.m. Farquhar sold $1.5 million under a 10b5-1 plan
  32. Aug 18, 2026Planned saleFarquhar John C.M. (officer, director) filed notice to sell about $1.5 million around Aug 18, 2026
  33. Aug 17, 2026Insider saleChief Medical Officer Campbell Rogers sold $380,099 under a 10b5-1 plan
  34. Aug 17, 2026Planned saleRogers Campbell (officer) filed notice to sell about $380,099 around Aug 17, 2026
  35. Aug 14, 2026Insider saleCEO John C.m. Farquhar sold $607,774 under a 10b5-1 plan
  36. Aug 10, 2026Insider saleCEO John C.m. Farquhar sold $638,730 under a 10b5-1 plan
  37. Jul 15, 2026Insider saleChief Medical Officer Campbell Rogers sold $237,113 under a 10b5-1 plan
  38. Jul 10, 2026Insider saleCEO John C.m. Farquhar sold $626,096 under a 10b5-1 plan
  39. Jun 30, 2026FundRenaissance Technologies opened a position in Q2 2026 (13F filed Aug 13, 2026)
  40. Jun 24, 2026Insider saleCEO John C.m. Farquhar sold $1.4 million under a 10b5-1 plan

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 26, 2026.

Recent HTFL insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 26Oct 22Campbell RogersChief Medical OfficerChief Medical Officer▼ SELL10b5-123,93355.01$1.32M−25%Form 4 ↗
Oct 14Oct 12John C.m. FarquharCEOCEO▼ SELL10b5-138,90049.57$1.93M−12%Form 4 ↗
Sep 21Sep 18Campbell RogersChief Medical OfficerChief Medical Officer▼ SELL10b5-119,68250.15$987K−20%Form 4 ↗
Sep 18Sep 18Vikram VergheseCFOCFO▼ SELL10b5-116,76650.75$851K−9.8%Form 4 ↗
Sep 18Sep 17Vikram VergheseCFOCFO▼ SELL10b5-17,57950.11$380K−4.2%Form 4 ↗
Sep 15Sep 11Vikram VergheseCFOCFO▼ SELL10b5-129,71450.06$1.49M−14%Form 4 ↗
Sep 15Sep 14Vikram VergheseCFOCFO▼ SELL10b5-14,59350.24$231K−2.5%Form 4 ↗
Sep 15Sep 15Vikram VergheseCFOCFO▼ SELL10b5-166850.01$33K−0.4%Form 4 ↗
Sep 14Sep 10John C.m. FarquharCEOCEO▼ SELL10b5-135,01046.42$1.63M−9.7%Form 4 ↗
Sep 14Sep 11John C.m. FarquharCEOCEO▼ SELL10b5-13,89050.00$195K−1.2%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 21 HTFL insider trades →

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Campbell RogersChief Medical Officer0$04$2.92MOct 26, 2026
John C.m. FarquharCEO0$09$9.81MOct 14, 2026
Vikram VergheseCFO0$08$4.98MSep 18, 2026

Buybacks and executive pay

Heartflow, Inc. spent $228,000 buying back its own shares in 2023.

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Filing quality

A All 21 insider trades reported on time. How it is graded

Tracked funds that report HTFL

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 2026382,700$11.2M0.02%▲ New
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →